// App-Quantinova.ai

37 EP897 : RET M918T-exon 16 mutation in subjects with sporadic medullary thyroid cancer (sMTC)

Researchers

Presenter

  • Miljenko Solter

Principal Investigators

  • Nora Nikolac

Medical Centers

  • Univeristy Hospital Centre Zagreb, Zagreb, Croatia

  • University Hospital Centre Sisters of Charity, Zagreb, Croatia

Locations

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Thyroid Cancer

  • Solid malignancies

Biomarkers

  • High affinity nerve growth factor receptor

Drug/Treatment

  • Cabozantinib

  • Calcitonin

  • methionine

  • Vandetanib

  • L-Tyrosine

  • S-methyl-L-thiocitrulline

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved